ACAN-Smallpox antiviral

Tender details

The tender seeks to negotiate a contract with Emergent Biodefense Operations Lansing LLC for the purchase of Tembexa® (brincidofovir), an antiviral specifically for treating smallpox. The limited tendering is justified as Emergent is the only known supplier capable of providing this specialized antiviral, particularly for pediatric patients. Other suppliers may express interest by submitting statements of capabilities before the closing date.